Kinetics of plasma total homocysteine in patients receiving high-dose methotrexate therapy

Clinical Chemistry

Volumn 44, Issue 9, 1998, Pages 1987-1989

  Guttormsen, Anne Berit ^a   Ueland, Per Magne ^a   Lønning, Per Eystein ^b   Mella, Olav ^b   Refsum, Helga ^a  

^a UNIVERSITY OF BERGEN   (Norway)

^b HAUKELAND UNIVERSITY HOSPITAL   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

HOMOCYSTEINE; METHOTREXATE;

ADULT; AMINO ACID BLOOD LEVEL; AMINO ACID METABOLISM; ARTICLE; CANCER; CANCER CHEMOTHERAPY; CLINICAL ARTICLE; FOLATE METABOLISM; HOMOCYSTINURIA; HUMAN; MALE; METHYLATION;

EID: 0031781360     PISSN: 00099147     EISSN: None     Source Type: Journal    
DOI: 10.1093/clinchem/44.9.1987     Document Type: Article

References (20)

1. Finkelstein JD. Methionine metabolism in mammals. J Nutr Biochem 1990; 1:228-37.
2. Allen RH, Stabler SP, Savage DG, Lindenbaum J. Diagnosis of cobalamin deficiency. 1. Usefulness of serum methylmalonic acid and total homocysteine concentrations. Am J Hematol 1990;34:90-8.
3. Guttormsen AB, Ueland PM, Nesthus I, Nygàrd O, Schneede J, Vollset SE, Refsum H. Determinants and vitamin responsiveness of intermediate hyperhomocysteinemia (≥40 μmol/liter). The Hordaland Homocysteine Study. J Clin Investig 1996;98:2174-83.
4. Brattström LE, Hultberg BL, Hardebo JE. Folic acid responsive postmenopausal homocysteinemia. Metabolism 1985;34:1073-7.
5. Huennekens FM. The methotrexate story: a paradigm for development of cancer chemotherapeutic agents. Adv Enzyme Regul 1994;34:397-419.
6. Ueland PM, Refsum H, Male R, Lillehaug JR. Disposition of endogenous homocysteine by mouse fibroblast C3H/10T1/2 CI 8 and the chemically transformed C3H/10T1/2MCA CI 16 cells following methotrexate exposure. J Natl Cancer Inst 1986;77:283-9.
7. Refsum H, Christensen B, Djurhuus R, Ueland PM. Interaction between methotrexate, "rescue" agents and cell proliferation as modulators of homocysteine export from cells in culture. J Pharmacol Exp Ther 1991;258: 559-66.
8. Fiskerstrand T, Ueland PM, Refsum H. Folate depletion induced by methotrexate affects methionine synthase activity and its susceptibility to inactivation by nitrous oxide. J Pharmacol Exp Ther 1997;282:1305-11.
9. Refsum H, Helland S, Ueland PM. Fasting plasma homocysteine as a sensitive parameter to antifolate effect. A study on psoriasis patients receiving low-dose methotrexate treatment. Clin Pharmacol Ther 1989;46: 510-20.
10. Refsum H, Ueland PM, Kvinnsland S. Acute and long-term effects of high-dose methotrexate treatment on homocysteine in plasma and urine. Cancer Res 1986;46:5385-91.
11. Guttormsen AB, Schneede J, Ueland PM, Refsum H. Kinetics of total plasma homocysteine in subjects with hyperhomocysteinemia due to folate or cobalamm deficiency. Am J Clin Nutr 1996;63:194-202.
12. Guttormsen AB, Mansoor MA, Fiskerstrand T, Ueland PM, Refsum H. Kinetics of plasma homocysteine in healthy subjects after peroral homocysteine loading. Clin Chem 1993;39:1390-7.
13. Fiskerstrand T, Refsum H, Kvalheim G, Ueland PM. Homocysteine and other thiols in plasma and urine: automated determination and sample stability. CIm Chem 1993;39:263-71.
14. Rowland M, Tozer TN. Clinical pharmacokinetics. Concepts and applications. 2nd ed. Philadelphia, PA: Lea & Febiger, 1989:546.
15. Guttormsen AB, Ueland PM, Svarstad E, Refsum H. Kinetic basis of hyperhomocysteinemia in patients with chronic renal failure. Kidney Int 1997;52:495-502.
16. Yamaoka K, Nakagawa T, Uno T. Application of Akaike's information criterion (AIC) in the evaluation of linear pharmacokinetic equations. J Pharmacokinet Biopharm 1978;6:165-75.
17. Welling PG. Pharmacokinetics. Processes and mathematics. Washington, DC: American Chemical Society, 1986:290.
18. Guttormsen AB, Schneede J, Fiskerstrand T, Ueland PM, Refsum H. Plasma concentrations of homocysteine and other aminothiol compounds are related to food intake in healthy human subjects. J Nutr 1994;124:1934-41.
19. Refsum H, Wesenberg F, Ueland PM. Plasma homocysteine in children with acute lymphoblastic leukemia. Changes during a chemotherapeutic regimen including methotrexate. Cancer Res 1991;51:828-35.
20. Broxson EH Jr, Stork LC, Allen RH, Stabler SP, Kolhouse JF. Changes in plasma methionine and total homocysteine levels in patients receiving methotrexate infusions. Cancer Res 1989;49:5879-83.